
Zimiplan-I.V Injection
Marketer
Astemax Biotech Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Zimiplan-I.V Injection
Intravenous Zimiplan reduces gastric acid production, treating stomach and intestinal conditions like acid reflux, peptic ulcers, and Zollinger-Ellison syndrome. It alleviates symptoms and facilitates healing. Administered intravenously by medical professionals, it's reserved for patients where injection is deemed preferable to oral medication. This proton pump inhibitor (PPI) also prevents stress ulcers in critically ill patients and pre-anesthetically to mitigate aspiration risks. Dosage and treatment duration are determined by your physician, and consistent use, as prescribed, is crucial even with rapid symptom relief. Dietary modifications, such as smaller, more frequent meals and avoidance of caffeine, spicy, and fatty foods, can enhance treatment effectiveness. Common, generally mild side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis. Persistent or bothersome side effects warrant medical consultation. Prolonged use, particularly exceeding one year, may increase bone fracture risk, especially at higher doses. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your doctor. Consult your physician before use if you have severe liver impairment, take HIV medications, have prior allergic reactions to similar drugs, or have osteoporosis. Pregnant or breastfeeding individuals should also seek medical advice. Alcohol should be avoided due to its acid-stimulating properties. Refrain from operating machinery if dizziness or drowsiness occurs.
Primary Ingredients of Zimiplan-I.V Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Zimiplan-I.V Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Zimiplan-I.V Injection:
This medication will be administered by your physician or registered nurse; please refrain from self-medicating.
Common Side effects of Zimiplan-I.V Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Zimiplan-I.V Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Zimiplan-I.V Injection works:
Gastric acid secretion is decreased by the proton pump inhibitor Zimiplan-I.V Injection, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Zimiplan-I.V Injection use poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Administering Zimiplan-I.V Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Intravenous Zimiplan administration during lactation appears unlikely to pose a substantial risk to the infant, based on the currently available, albeit limited, clinical data in humans.
DrivingCONSULT YOUR DOCTOR
The effect of Zimiplan-I.V Injection on driving ability is unknown. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Intravenous Zimiplan administration is considered safe for individuals with renal impairment. No alteration of the Zimiplan I.V. Injection dosage is necessary.
LiverCAUTION
Intravenous Zimiplan administration requires careful consideration in individuals with significant hepatic impairment. Dosage modification of Zimiplan I.V. may be necessary. Physician consultation is advised.
What if you forget to take Zimiplan-I.V Injection :
Omit a Zimiplan-I.V Injection dose? Seek your physician's advice.
Facts to Know About Zimiplan-I.V Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Category | Gastric acid suppressants |
